This page contains enriched content visible when JavaScript is enabled.
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Author: Omuro, Antonio. Published in: Neuro-Oncology, v. 15 no. 2, pp. 242- 250 Date: 2013
ISSN: 1522-8517, EISSN: 1523-5866 DOI: 10.1093/neuonc/nos295
Get full text via these sources:
Oxford Journals Online
PubMED Central
EBSCOhost: Medline Complete
Any issues, please contact the library for help:
Contact us